Childrens Hospital & Clinics of Minnesota

Minneapolis, Minnesota 55404-4597

0 studies enrolling now · 11 studies all time

What they study most

Acute Lymphoblastic Leukemia, Cystic Fibrosis, Deep Vein Thrombosis (DVT), Hodgkin's Disease, Hyperbilirubinemia, Leukemia, Lymphoblastic, Acute, Leukemia, Lymphoblastic, Acute, T Cell, Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Myelogenous Leukemia, Acute, Childhood, Non-Hodgkin's Lymphoma

Studies at this site

• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) — Completed
• A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Participants With an F508del CFTR Mutation — Completed
• EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) — Stopped early
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma — Completed
• A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML — Completed
• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL — Stopped early
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL — Stopped early
• Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) — Completed
• T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) — Stopped early
• Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department — Completed
• A Study Of Panobinostat In Children With Refractory Hematologic Malignancies — Completed